-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BZkknCo7oxxKM5LIAzYQQvr0VpU73BAlbO2GAqnbKzbUTe4/DY5TmI/PXVHhU5k9 C+BbhfmwHWLbjj4ksxvOuA== 0000904454-07-000037.txt : 20070131 0000904454-07-000037.hdr.sgml : 20070131 20070131153404 ACCESSION NUMBER: 0000904454-07-000037 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070131 DATE AS OF CHANGE: 20070131 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79927 FILM NUMBER: 07568020 BUSINESS ADDRESS: STREET 1: 43 MOULTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6174919700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MVM International Life Sciences Fund No 1 L P CENTRAL INDEX KEY: 0001296587 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 6 HENRIETTA STREET CITY: LONDON STATE: X0 ZIP: WC2E8PIU BUSINESS PHONE: 44-2075577517 MAIL ADDRESS: STREET 1: 6 HENRIETTA STREET CITY: LONDON STATE: X0 ZIP: WC2E8PIU SC 13G/A 1 s13ga_123106-momenta.txt AMD TO SCHED 13G FOR MOMENTA BY MVM INTERNATIONAL CUSIP No. 60877T 10 1 Page 1 of 5 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)[1] Momenta Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.0001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 60877T 10 1 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2006 - -------------------------------------------------------------------------------- Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ X ] Rule 13d-1(d) - --------------------------------------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 60877T 10 1 Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1) Name of Reporting Person MVM International Life I.R.S. Identification Sciences Fund No. 1, L.P. No. of Above Person (Entities Only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place United Kingdom of Organization - -------------------------------------------------------------------------------- Number of 5) Sole Voting -0- Shares Beneficially Power Owned by Each Reporting Person With ------------------------------------------------- 6) Shared Voting 1,369,696 shares Power of Common Stock ------------------------------------------------- 7) Sole Disposi- -0- tive Power ------------------------------------------------- 8) Shared Dis- 1,369,696 shares positive Power of Common Stock ------------------------------------------------- 9) Aggregate Amount Beneficially 1,369,696 shares Owned by Each Reporting person of Common Stock - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - -------------------------------------------------------------------------------- 11) Percent of Class Represented by 3.8% Amount in Row (9) - -------------------------------------------------------------------------------- 12) Type of Reporting Person PN CUSIP No. 60877T 10 1 Page 3 of 5 Pages - -------------------------------------------------------------------------------- 1) Name of Reporting Person MVM Life Science I.R.S. Identification Partners L.P. No. of Above Person (Entities Only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place United Kingdom of Organization - -------------------------------------------------------------------------------- Number of 5) Sole Voting -0- Shares Beneficially Power Owned by Each Reporting Person With ------------------------------------------------- 6) Shared Voting 7,880 shares Power of Common Stock ------------------------------------------------- 7) Sole Disposi- -0- tive Power ------------------------------------------------- 8) Shared Dis- 7,880 shares positive Power of Common Stock ------------------------------------------------- 9) Aggregate Amount Beneficially 7,880 shares Owned by Each Reporting person of Common Stock - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - -------------------------------------------------------------------------------- 11) Percent of Class Represented by less than 0.1% Amount in Row (9) - -------------------------------------------------------------------------------- 12) Type of Reporting Person 00 CUSIP No. 60877T 10 1 Page 4 of 5 Pages AMENDMENT NO. 2 TO SCHEDULE 13G (FINAL AMENDMENT) Reference is hereby made to the statement on Schedule 13G originally filed with the Securities and Exchange Commission on January 27, 2005 and Amendment No. 1 thereto filed on January 26, 2006 (as so amended, the "Schedule 13G".) Terms defined in the Schedule 13G are used herein as so defined. The following Items of the Schedule 13G are hereby amended and restated to read in their entirety as follows: Item 4 - Ownership. (a) Amount Beneficially Owned: MVM Fund No. 1: 1,369,696 shares of Common Stock MVM : 7,880 shares of Common Stock (b) Percent of Class: MVM Fund No. 1: 3.8% MVM: less than 0.1% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: -0- (ii) shared power to vote or to direct the vote: MVM Fund No. 1: 1,369,696 shares of Common Stock MVM: 7,880 shares of Common Stock (iii) sole power to dispose or to direct the disposition of: -0- (iv) shared power to dispose or to direct the disposition of: MVM Fund No. 1: 1,369,696 shares of Common Stock MVM: 7,880 shares of Common Stock Item 5 - Ownership Of Five Percent Or Less Of A Class If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following: [X] CUSIP No. 60877T 10 1 Page 5 of 5 Pages Signature: After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. By /s/ Hugo Harrod ------------------------ Finance Manager MVM LIFE SCIENCE PARTNERS LLP By /s/ Hugo Harrod ------------------------ Member Date: January 25, 2007 -----END PRIVACY-ENHANCED MESSAGE-----